Joan Chypyha

Joan Chypyha is a declared insider of Edesa Biotech, Inc., with filings sourced from SEC (Form 4). We count 3 filings; the first trade dates from 23 May 2023 and the latest from 27 May 2026.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

On 1 June 2026 came the latest disclosure, a share grant in Edesa Biotech, Inc. The median gap between a trade and its publication by SEC (Form 4) is 5 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.